From Casetext: Smarter Legal Research

Classen Immunotherapies, Inc. v. Somaxon Pharm.

United States Court of Appeals for the Federal Circuit
Jan 17, 2014
550 F. App'x 897 (Fed. Cir. 2014)

Opinion

2013-1405

01-17-2014

CLASSEN IMMUNOTHERAPIES, INC., Plaintiff-Appellant, v. SOMAXON PHARMACEUTICALS, Defendant-Appellee.

JOSEPH J. ZITO, DNL ZITO, of Washington, DC, argued for plaintiff-appellant. With him on the brief was BENJAMIN C. DEMING, of Los Angeles, California. LISA J. PIROZZOLO, Wilmer Cutler Pickering Hale and Dorr, LLP, of Boston, Massachusetts, argued for defendant-appellee. With her on the brief were MARK C. FLEMING, and DAVID A. MANSPEIZER, of New York, New York.


NOTE: This disposition is nonprecedential.

Appeal from the United States District Court for the Central District of California in No. 12-CV-6643, Judge Gary Feess.

JUDGMENT

JOSEPH J. ZITO, DNL ZITO, of Washington, DC, argued for plaintiff-appellant. With him on the brief was BENJAMIN C. DEMING, of Los Angeles, California.

LISA J. PIROZZOLO, Wilmer Cutler Pickering Hale and Dorr, LLP, of Boston, Massachusetts, argued for defendant-appellee. With her on the brief were MARK C. FLEMING, and DAVID A. MANSPEIZER, of New York, New York. THIS CAUSE having been heard and considered, it is ORDERED AND ADJUDGED:

PER CURIAM (NEWMAN, DYK, and MOORE, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

__________

Daniel E. O'Toole

Clerk of Court


Summaries of

Classen Immunotherapies, Inc. v. Somaxon Pharm.

United States Court of Appeals for the Federal Circuit
Jan 17, 2014
550 F. App'x 897 (Fed. Cir. 2014)
Case details for

Classen Immunotherapies, Inc. v. Somaxon Pharm.

Case Details

Full title:CLASSEN IMMUNOTHERAPIES, INC., Plaintiff-Appellant, v. SOMAXON…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jan 17, 2014

Citations

550 F. App'x 897 (Fed. Cir. 2014)

Citing Cases

Classen Immunotherapies, Inc. v. Shionogi, Inc.

Essentially, they describe a database management methodology for evaluating the efficacy of a therapeutic…

Classen Immunotherapies, Inc. v. Shionogi, Inc.

This decision was affirmed without opinion by the Court of Appeals for the Federal Circuit on January 17,…